Danaher Corporation (DHR): Officer sold ~$879K

~$879K

Approx. value · 4,176 sh @ $210.44

3,623

Holds after · shares reported

Traded

Nov 10, 2025

Filed

Nov 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 29, 2024CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
2. Apr 28, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
3. Sep 3, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
4. Sep 25, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
5. Oct 7, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
6. Oct 21, 2025Company filing · Form 8-K · ResultsReported its results
7. Oct 30, 2025FDARecall: Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GXBCRABL-10
8. Oct 31, 2025Insider · 1 personInsiders: 3 sales (~$129.6M)
9. Nov 5, 2025FDARecall: Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
10. Nov 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 6, 2025, John T. Schwieters notified Danaher’s Board of Directors (“Board”) that he has decided not to stand for reelection at the Company’s 2026 annual meeting of shareholders (“2026 Annual Meeting”), and will retire from the Danaher Board as of the 2026 Annual Meeting.”
11. Nov 7, 2025FDARecall: Access 2 Reaction Vessels, individual, disposable, plastic tubes used to process patient, quality control and calibration samples on the Access 2 Immunoassay s…
12. Nov 10, 2025 · this disclosureInsiderOfficer sold ~$879K of DHR shares in the open market

What came next

1. Nov 10, 2025FDARecall: COULTER DxH Diluent, REF 628017 COULTER DxH ECO Diluent REF C67250 For use as an isotonic buffered diluent in conjunction with a cyanide-free lytic agent for c…
2. Nov 10, 2025InsiderOfficer sold ~$210K of DHR shares in the open market
3. Nov 11, 2025InsiderCFO sold ~$3.47M of DHR shares in the open market
4. Nov 12, 2025Insider · 2 peopleInsiders: 6 sales (~$100.3M)
5. Nov 13, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
6. Nov 17, 2025FDAFDA device clearance: Access Rubella IgG
7. Nov 18, 2025InsiderDirector sold ~$747K of DHR shares in the open market
8. Nov 25, 2025Insider · 1 personInsiders: 2 sales (~$9.4M)
9. Nov 26, 2025FDARecall: Beckman Coulter UniCel Dxl 600, Part numbers: A71460, A71461, A30260; Immunoassay Method, Troponin Subunit
10. Nov 26, 2025FDARecall: Beckman Coulter UniCel Dxl 800, Part numbers: 973100, A71456, A71457, A25288; Immunoassay Method, Troponin Subunit
11. Dec 8, 2025FDARecall: The LDL-Cholesterol assay is comprised of two distinct phases. In phase one a unique detergent solubilizes cholesterol from non-LDL- lipoprotein particles. Thi…
12. Dec 18, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
13. Dec 23, 2025FDARecall: CellMek SPS Sample Preparation System, REF: C44603, with software
14. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
15. Jan 16, 2026FDAFDA device clearance: Xpert GI Panel
16. Jan 27, 2026FDAFDA device clearance: Access anti-HAV IgM
17. Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
18. Jan 30, 2026FDARecall: CHEMISTRY ANALYZER AU5800, REF: B96697, B96698, B23279, B23280, B23281
19. Jan 30, 2026FDARecall: DxC 700 AU, REF: B86444, B86446
20. Jan 30, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 8.6%

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Georgeann Couchara, SVP, Human Resources

• SEC Form 4 at Danaher Corporation (DHR)Nov 12, 2025

The full history of Georgeann Couchara, SVP, Human Resources is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Danaher Corporation

• SEC Form 144Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026

Everything OQRO holds on this company is on its DHR page.